All Curated Mutation Sites in HPV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All

E1^E4

Keyword: Uterine Cervical Diseases-37759219

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	37759219	A646C	E7	E7	Uterine Cervical Diseases	G R S L	View
2	37759219	C790T	E7	E7	Uterine Cervical Diseases	G R S L	View
3	37759219	G597A	E7	E7	Uterine Cervical Diseases	G R S L	View
4	37759219	G663A	E7	E7	Uterine Cervical Diseases	G R S L	View
5	37759219	G666A	E7	E7	Uterine Cervical Diseases	G R S L	View
6	37759219	G753C	E7	E7	Uterine Cervical Diseases	G R S L	View
7	37759219	G781C	E7	E7	Uterine Cervical Diseases	G R S L	View
8	37759219	G823C	E7	E7	Uterine Cervical Diseases	G R S L	View
9	37759219	T760C	E7	E7	Uterine Cervical Diseases	G R S L	View
10	37759219	T843C	E7	E7	Uterine Cervical Diseases	G R S L	View
11	37759219	T846C	E7	E7	Uterine Cervical Diseases	G R S L	View
12	37759219	A131C	E6	E6	Uterine Cervical Diseases	G R S L	View
13	37759219	A184G	E6	E6	Uterine Cervical Diseases	G R S L	View
14	37759219	A276G	E6	E6	Uterine Cervical Diseases	G R S L	View
15	37759219	A306C	E6	E6	Uterine Cervical Diseases	G R S L	View
16	37759219	A426C	E6	E6	Uterine Cervical Diseases	G R S L	View
17	37759219	A442C	E6	E6	Uterine Cervical Diseases	G R S L	View
18	37759219	A95G	E6	E6	Uterine Cervical Diseases	G R S L	View
19	37759219	C153T	E6	E6	Uterine Cervical Diseases	G R S L	View
20	37759219	C158A	E6	E6	Uterine Cervical Diseases	G R S L	View
21	37759219	C173T	E6	E6	Uterine Cervical Diseases	G R S L	View
22	37759219	C335T	E6	E6	Uterine Cervical Diseases	G R S L	View
23	37759219	C387T	E6	E6	Uterine Cervical Diseases	G R S L	View
24	37759219	D32E	E6	E6	Uterine Cervical Diseases	G R S L	View
25	37759219	D32N	E6	E6	Uterine Cervical Diseases	G R S L	View
26	37759219	E36Q	E6	E6	Uterine Cervical Diseases	G R S L	View
27	37759219	G176A	E6	E6	Uterine Cervical Diseases	G R S L	View
28	37759219	G188C	E6	E6	Uterine Cervical Diseases	G R S L	View
29	37759219	G395T	E6	E6	Uterine Cervical Diseases	G R S L	View
30	37759219	G489A	E6	E6	Uterine Cervical Diseases	G R S L	View
31	37759219	G553T	E6	E6	Uterine Cervical Diseases	G R S L	View
32	37759219	G94A	E6	E6	Uterine Cervical Diseases	G R S L	View
33	37759219	H31Y	E6	E6	Uterine Cervical Diseases	G R S L	View
34	37759219	I34M	E6	E6	Uterine Cervical Diseases	G R S L	View
35	37759219	K75T	E6	E6	Uterine Cervical Diseases	G R S L	View
36	37759219	L35V	E6	E6	Uterine Cervical Diseases	G R S L	View
37	37759219	L45P	E6	E6	Uterine Cervical Diseases	G R S L	View
38	37759219	N65S	E6	E6	Uterine Cervical Diseases	G R S L	View
39	37759219	T109C	E6	E6	Uterine Cervical Diseases	G R S L	View
40	37759219	T137G	E6	E6	Uterine Cervical Diseases	G R S L	View
41	37759219	T178A	E6	E6	Uterine Cervical Diseases	G R S L	View
42	37759219	T178G	E6	E6	Uterine Cervical Diseases	G R S L	View
43	37759219	T185G	E6	E6	Uterine Cervical Diseases	G R S L	View
44	37759219	T216C	E6	E6	Uterine Cervical Diseases	G R S L	View
45	37759219	T241G	E6	E6	Uterine Cervical Diseases	G R S L	View
46	37759219	T292C	E6	E6	Uterine Cervical Diseases	G R S L	View
47	37759219	T350G	E6	E6	Uterine Cervical Diseases	G R S L	View

Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.